Italy - Healthcare, Regulatory and Reimbursement Landscape

Italy - Healthcare, Regulatory and Reimbursement Landscape

  • October 2021 •
  • 154 pages •
  • Report ID: 6169592 •
  • Format: PDF
Italy - Healthcare, Regulatory and Reimbursement Landscape

Summary
The analyst has released its latest report, “Italy - Healthcare, Regulatory and Reimbursement Landscape”.The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Italy.

It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure.Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.

Italy is one of the most significant pharmaceutical markets in Europe based on pharmaceutical production, exportation, innovative medicines, and biosimilar substitution.Universal healthcare coverage, high levels of innovation, and increasing use of biologics and biosimilars are factors driving the pharmaceutical and healthcare market.

However, generic substitution and drug pricing agreements may impede market growth. The market value, in terms of euros, increased from €19.5B in 2013 to €22.9B in 2020 at a Compound Annual Growth Rate (CAGR) of 2.3%. In terms of US dollars, the market increased from $25.8B in 2013 to $26.2B in 2020 at a CAGR of 0.8%. The medical devices market of Italy was $8.57B in 2017, which increased at a CAGR of 2.2% to reach $9.16B in 2020. The market is expected to grow at a CAGR of 4.65% from $10.77B in 2021 to reach $11.50B in 2025.

Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Italy, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Bayer, Boehringer Ingelheim, Merck, and Chiesi
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, GE Healthcare, Roche Diagnostics, and Amplifon
- An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Italian healthcare market

Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Italy’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Italian healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
Loading...

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.